Novo Nordisk to launch discounted Wegovy subscriptions for self-pay patients in US

Slash Your Wegovy Costs: Novo Nordisk Reveals First-Ever Subscription Plan - Novo Nordisk (NYSE:NVO)

Novo Nordisk launches the first Wegovy subscription program. Save on injections and pills through Ro, WeightWatchers, LifeMD, and more.

Novo hits back at rivals with cut-price Wegovy subscriptions

Trying to claw back market share in the weight-loss category, Novo Nordisk has launched a subscription-based service for Wegovy cash payers

Novo Nordisk to launch discounted Wegovy subscription plan

Novo Nordisk launches a new Wegovy subscription as it trails Eli Lilly in the weight loss drug race

The program launched through telehealth providers Ro, WeightWatchers, and LifeMD, with Hims & Hers and Sesame to follow

Wegovy Subscription Launched—Will Save Users Up To $1,200 Per Year, Novo Nordisk Says

Novo Nordisk says people will save up to $1,200 per year on the Wegovy injection and $600 per year on the pill under the new program.

Novo Nordisk launches first and only multi-month subscription program for FDA-approved Wegovy®, offering savings of up to $1,200/year (2026-03-31)

Patients can save up to $600/ year on the Wegovy ® pill and up to $1,200/ year on the Wegovy ® injection with a 12- month subscription and should contact their telehealth providers directly for eligibility and enrollment details. 3- month subscription: $329/ month, a savings of $240 per year 6- month subscription: $299/ month, a savings of $600 per year 12‑ month...